Drug Safety Debate Will Have Long-Term Effect On New Approvals, Troy Says

The current debate over drug safety will have a visible impact on new drug approvals in up to three years, former FDA Chief Counsel Dan Troy said

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet